Klaus Thirring

Title: Klaus Thirring: Innovator in Anti-inflammatory Research

Introduction

Klaus Thirring is a notable inventor based in Wien, Austria. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-inflammatory compounds. His work has the potential to impact the treatment of various diseases associated with inflammation.

Latest Patents

Klaus Thirring holds a patent for "Antiinflammatory lactones - Lactones of Formula (I) which are pharmaceutically active in diseases associated with inflammation." This patent highlights his innovative approach to addressing inflammatory conditions through novel chemical compounds. He has 1 patent to his name, showcasing his expertise in this specialized area.

Career Highlights

Throughout his career, Klaus Thirring has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Novartis AG and Nabriva Therapeutics GmbH. His experience in these organizations has allowed him to contribute to significant advancements in drug development and therapeutic solutions.

Collaborations

Klaus Thirring has collaborated with esteemed colleagues such as Josef Gottfried Meingassner and Werner Heilmayer. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of pharmaceutical research.

Conclusion

Klaus Thirring's contributions to anti-inflammatory research and his patent for novel lactones demonstrate his commitment to advancing medical science. His work continues to inspire future innovations in the treatment of inflammatory diseases.